Thrombosis News and Research

Latest Thrombosis News and Research

Computers pass dosage test for thrombosis drugs

The largest ever study into the administration of blood thinning drugs like Warfarin has concluded that dosages calculated by computer are at least as safe and reliable as those provided by trained medical professionals.

From The University of Manchester 20 Jul 2007

Venous thromboembolism in the U.S.

Venous thrombosis (VTE), the formation of blood clots in a vein, is a major health problem for hospitalized patients in the United States.

16 Jul 2007

Barr confirms patent challenge of Aggrenox

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Boehringer Ingelheim in connection with its Aggrenox Aspirin/Extended- Release Dipyridamole) 25 mg/200 mg capsules.

13 Jul 2007

Four hours in ecomony class doubles the risk for deep vein thrombosis

According to the World Health Organization (WHO) the chances of developing deep vein thrombosis ( DVT) double after traveling for four hours or more; this says WHO equates to one in 6,000 long-haul passengers at risk of potentially dangerous blood clots.

2 Jul 2007

Aspirin resistance

Aspirin is used by millions of patients for the prevention and treatment of coronary artery disease, the single leading cause of death in the world.

17 Jun 2007

Folic acid may lower the risk of stroke

Researchers in the United States say folic acid supplements may reduce the risk of stroke by more than 18 percent.

4 Jun 2007

3-D plasma coating technique keeps veins and arteries open

Scientists at the University of Ulster are working on a new method of coating stents – the medical devices used to keep veins and arteries open – to prevent them blocking up.

30 May 2007

System allows autistic children to communicate with their environment

Communication ability among children who are intellectually disabled or have communication limitations (such as autism, down syndrome, or cerebral palsy) may soon be improved thanks to a research group of the University of Granada.

30 May 2007

Long-term treatment with anti-clotting drug clopidogrel improves stenting outcomes in diabetic patients

A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI).

18 May 2007

Pycnogenol natural pine bark extract reduces heart failure

A study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart.

17 May 2007

Merits and risks of postmenopausal hormone therapy

The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.

17 May 2007

High-dose clopidogrel before stenting cuts heart attack risk in half

Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention (PCI) cuts the combined risk of heart attack and cardiac death by half, according to a study reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 9-12, 2007, in Orlando, FL.

15 May 2007

Role of PCI and coronary artery bypass grafting for the treatment of patients with left main coronary artery disease

Coronary artery bypass surgery has been the preferred treatment for patients with a blockage in the left main coronary artery, the conduit that supplies blood to about two-thirds of the heart.

15 May 2007

Stent thrombosis

Over the last year, it's been rare to utter the word "stent" without at least thinking "thrombosis," an uncommon but serious complication that's been on the minds of interventional cardiologists and patients alike.

11 May 2007

Recent developments for drug-eluting stents

Drug-eluting stents -- small metal tubes used to prop open clogged arteries -- have been garnering headlines.

10 May 2007

Off-label and untested use of drug-coated stents is common in U.S. practice

The off-label and untested use of drug-coated stents in the treatment of coronary artery blockage is common in U.S. practice, and ischemic complication rates are higher among patients receiving drug-coated stents for off-label indications, according to two studies in the May 9 issue of Journal of the American Medical Association.

9 May 2007

Contrast-enhanced ultrasound after liver transplant is highly accurate in showing vascular as well as biliary complications

The study consisted of 39 liver transplant recipients who underwent a CE-US exam after developing fluid in the abdomen and/or unclear liver function tests.

8 May 2007

Scientists delete enzyme in mice so they can eat any type of fat and not get heart disease

A new study in mice raises a tantalizing possibility, that humans may one day be able to eat any kind of fat they want without raising their risk of heart disease.

8 May 2007

Caution against over-aggressive use of erythropoiesis-stimulating agents for cancer-related anemia

Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" (ESAs) to treat anemia in some cancer patients, according to a commentary in the April issue of The Oncologist, published by AlphaMed Press.

1 May 2007

Researchers identify antioxidant mechanisms involved in protection against heart disease

Zvonimir Katusic, M.D., Ph.D., and Mayo colleagues have identified antioxidant mechanisms essential for regenerative function of endothelial progenitor cells (EPCs).

30 Apr 2007